EHA 2025
30th edition of the event organized by the European Association of Hematology
EHA 2025
30th edition of the event organized by the European Association of Hematology
EHA 2025 in Milan is the leading European congress for hematology. It brings together world experts in leukemia, lymphoma, myeloma, and advanced therapies such as CAR-T and transplants. Focus on personalized medicine and applied genetics offers new therapeutic perspectives, crucial for improving patient outcomes and quality of life.
EHA 2025 in Milan is the leading European congress for hematology. It brings together world experts in leukemia, lymphoma, myeloma, and advanced therapies such as CAR-T and transplants. Focus on personalized medicine and applied genetics offers new therapeutic perspectives, crucial for improving patient outcomes and quality of life.
Discovery of "Monza" hemoglobin and its clinical implications
it
Prof. Carlo Gambacorti-Passerini
Treatment of myelofibrosis with JAK inhibitors. The efficacy of momelotinib
en
Prof. Christoph Scheid
From Fanconi anemia to leukemia: a path through molecular aberrations
en
Prof. Jean Soulier
Lymphoblastic leukemia: limitations of immunotherapy for pediatric patients
it
Prof. Andrea Biondi
New classification of High-Risk Multiple Myeloma
en
Prof. Pieter Sonneveld
Immune functions and sterile inflammation in Sickle Cell Disease
en
Dr. Francesca Vinchi
Myelofibrosis and impact of anemia in patients treated with ruxolitinib
en
Dr. Pankit Vachhani
Emergence of rare anemias using extensive sequencing techniques
en
Dr. María del Mar Mañú Pereira
Chronic myeloid leukemia: effects of imatinib use on disease management
it
Prof. Carlo Gambacorti-Passerini
Building a reliable and validated test to identify Leukemic Stem Cells in AML
en
Dr. Tom Reuvekamp